Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 07, 2026 Filed Jul 9, 2026 23:42 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 676.1368 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-26-000019 · wk-form4_1783640539.xml · derivative · entry 9 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,871.5515 Underlying: Common Shares · 676.1368 shares Expires 2030-05-21 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025-2 PBRSUs") granted to the Reporting Person. The 2025-2 PBRSUs will have a performance period beginning May 15, 2025 and ending May 21, 2028 and to the extent earned will vest on May 21, 2030. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 23:42 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 640.7423 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-26-000019 · wk-form4_1783640539.xml · derivative · entry 8 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,847.4668 Underlying: Common Shares · 640.7423 shares Expires 2028-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025-1 PBRSUs") granted to the Reporting Person. The 2025-1 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 23:42 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 69.8961 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-26-000019 · wk-form4_1783640539.xml · derivative · entry 7 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,946.651 Underlying: Common Shares · 69.8961 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 23:42 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 445.3362 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-26-000019 · wk-form4_1783640539.xml · derivative · entry 6 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,631.3051 Underlying: Common Shares · 445.3362 shares Expires 2027-03-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 23:42 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 66.8518 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-26-000019 · wk-form4_1783640539.xml · derivative · entry 5 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,600.5297 Underlying: Common Shares · 66.8518 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. Read SEC document |
| July 07, 2026 Filed Jul 9, 2026 23:42 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 22.0163 | $0.00 | $0.00 |
DisclosureSEC source: 0001829353-26-000019 · wk-form4_1783640539.xml · derivative · entry 4 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,503.086 Underlying: Common Shares · 22.0163 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 21:01 UTC |
SMITH MARCIA MARIEDirector
|
GrantOption (Right to Buy) · Derivative | 13,747 | $0.00 Strike: $72.74 | $0.00 |
DisclosureSEC source: 0002137948-26-000006 · wk-form4_1780952514.xml · derivative · entry 1 SMITH MARCIA MARIE · CIK 0002137948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,747 Underlying: Common Shares · 13,747 shares Expires 2036-06-03 F1 · derivative.exercise_price: The options were issued with an exercise price of CAD $101.09. The reported exercise price represents the U.S. dollar equivalent at the time of grant following conversion using the Bank of Canada daily exchange rate on the grant date. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 314.4494 | $0.00 | $0.00 |
DisclosureSEC source: 0001908101-26-000015 · wk-form4_1775519283.xml · derivative · entry 11 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,645.4494 Underlying: Common Shares · 314.4494 shares Expires 2029-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted shares units ("2026 PBRSUs") granted to the Reporting Person. The 2026 PBRSUs will have a performance period beginning February 25, 2026 and ending February 25, 2029 and to the extent earned will vest on March 15, 2029. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 68.6698 | $0.00 | $0.00 |
DisclosureSEC source: 0001908101-26-000015 · wk-form4_1775519283.xml · derivative · entry 10 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,002.6698 Underlying: Common Shares · 68.6698 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 296.0286 | $0.00 | $0.00 |
DisclosureSEC source: 0001908101-26-000015 · wk-form4_1775519283.xml · derivative · entry 9 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,498.7219 Underlying: Common Shares · 296.0286 shares Expires 2028-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 49.0449 | $0.00 | $0.00 |
DisclosureSEC source: 0001908101-26-000015 · wk-form4_1775519283.xml · derivative · entry 8 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,715.616 Underlying: Common Shares · 49.0449 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 246.0792 | $0.00 | $0.00 |
DisclosureSEC source: 0001908101-26-000015 · wk-form4_1775519283.xml · derivative · entry 7 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,677.6965 Underlying: Common Shares · 246.0792 shares Expires 2027-03-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 46.068 | $0.00 | $0.00 |
DisclosureSEC source: 0001908101-26-000015 · wk-form4_1775519283.xml · derivative · entry 6 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,368.6913 Underlying: Common Shares · 46.068 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 22.3327 | $0.00 | $0.00 |
DisclosureSEC source: 0001908101-26-000015 · wk-form4_1775519283.xml · derivative · entry 5 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,602.6142 Underlying: Common Shares · 22.3327 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
SANTELMO THIAGO TPresident, International
|
GrantPerformance Share Units · Derivative | 415.0826 | $0.00 | $0.00 |
DisclosureSEC source: 0002015936-26-000019 · wk-form4_1775519228.xml · derivative · entry 12 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,373.0826 Underlying: Common Shares · 415.0826 shares Expires 2029-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted shares units ("2026 PBRSUs") granted to the Reporting Person. The 2026 PBRSUs will have a performance period beginning February 25, 2026 and ending February 25, 2029 and to the extent earned will vest on March 15, 2029. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 137.8589 | $0.00 | $0.00 |
DisclosureSEC source: 0002015936-26-000019 · wk-form4_1775519228.xml · derivative · entry 11 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,065.8589 Underlying: Common Shares · 137.8589 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
SANTELMO THIAGO TPresident, International
|
GrantPerformance Share Units · Derivative | 357.99 | $0.00 | $0.00 |
DisclosureSEC source: 0002015936-26-000019 · wk-form4_1775519228.xml · derivative · entry 10 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,719.6035 Underlying: Common Shares · 357.99 shares Expires 2028-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning on February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 48.0216 | $0.00 | $0.00 |
DisclosureSEC source: 0002015936-26-000019 · wk-form4_1775519228.xml · derivative · entry 9 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,596.3663 Underlying: Common Shares · 48.0216 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
SANTELMO THIAGO TPresident, International
|
GrantPerformance Share Units · Derivative | 265.0277 | $0.00 | $0.00 |
DisclosureSEC source: 0002015936-26-000019 · wk-form4_1775519228.xml · derivative · entry 8 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,885.918 Underlying: Common Shares · 265.0277 shares Expires 2027-03-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 26.2292 | $0.00 | $0.00 |
DisclosureSEC source: 0002015936-26-000019 · wk-form4_1775519228.xml · derivative · entry 7 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,056.7061 Underlying: Common Shares · 26.2292 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
SANTELMO THIAGO TPresident, International
|
GrantRestricted Share Units · Derivative | 18.9263 | $0.00 | $0.00 |
DisclosureSEC source: 0002015936-26-000019 · wk-form4_1775519228.xml · derivative · entry 6 SANTELMO THIAGO T · CIK 0002015936 · President, International 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,205.6431 Underlying: Common Shares · 18.9263 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 503.1312 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-26-000014 · wk-form4_1775519277.xml · derivative · entry 8 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,634.1312 Underlying: Common Shares · 503.1312 shares Expires 2029-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted shares units ("2026 PBRSUs") granted to the Reporting Person. The 2026 PBRSUs will have a performance period beginning February 25, 2026 and ending February 25, 2029 and to the extent earned will vest on March 15, 2029. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 66.7224 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-26-000014 · wk-form4_1775519277.xml · derivative · entry 7 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,775.7224 Underlying: Common Shares · 66.7224 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 550.7587 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-26-000014 · wk-form4_1775519277.xml · derivative · entry 6 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,184.5687 Underlying: Common Shares · 550.7587 shares Expires 2028-03-15 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 63.1731 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-26-000014 · wk-form4_1775519277.xml · derivative · entry 5 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,362.0984 Underlying: Common Shares · 63.1731 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. F7 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantPerformance Share Units · Derivative | 553.6783 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-26-000014 · wk-form4_1775519277.xml · derivative · entry 4 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,524.8171 Underlying: Common Shares · 553.6783 shares Expires 2027-03-15 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 67.3444 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-26-000014 · wk-form4_1775519277.xml · derivative · entry 3 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,848.2118 Underlying: Common Shares · 67.3444 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:48 UTC |
CURTIS THOMAS BENJAMINPres., BK US & CA
|
GrantRestricted Share Units · Derivative | 21.7299 | $0.00 | $0.00 |
DisclosureSEC source: 0001804729-26-000014 · wk-form4_1775519277.xml · derivative · entry 2 CURTIS THOMAS BENJAMIN · CIK 0001804729 · Pres., BK US & CA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,532.3637 Underlying: Common Shares · 21.7299 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F2 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F3 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. F3 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantPerformance Share Units · Derivative | 7,236.3864 | $0.00 | $0.00 |
DisclosureSEC source: 0001337160-26-000005 · wk-form4_1775519240.xml · derivative · entry 5 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 843,317.3428 Underlying: Common Shares · 7,236.3864 shares Expires not disclosed F5 · derivative.exercise_price: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. F5 · derivative.exercise_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. F5 · derivative.expiration_date: The performance based restricted share units ("PBRSUs") will have a performance period beginning November 21, 2022 and ending May 21, 2028 and may be earned from 50% for the threshold performance to 200% for maximum performance, based on meeting performance targets tied to the appreciation of the price of RBI common shares. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
DOYLE J PATRICKDirector · Executive Chairman
|
GrantRestricted Share Units · Derivative | 1,929.7031 | $0.00 | $0.00 |
DisclosureSEC source: 0001337160-26-000005 · wk-form4_1775519240.xml · derivative · entry 4 DOYLE J PATRICK · CIK 0001337160 · Director · Executive Chairman 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,884.6247 Underlying: Common Shares · 1,929.7031 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on November 21, 2026 and November 21, 2027. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on November 21, 2026 and November 21, 2027. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 364.7703 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-26-000020 · wk-form4_1775519234.xml · derivative · entry 10 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,509.7703 Underlying: Common Shares · 364.7703 shares Expires 2029-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted shares units ("2026 PBRSUs") granted to the Reporting Person. The 2026 PBRSUs will have a performance period beginning February 25, 2026 and ending February 25, 2029 and to the extent earned will vest on March 15, 2029. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 120.7304 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-26-000020 · wk-form4_1775519234.xml · derivative · entry 9 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,069.7304 Underlying: Common Shares · 120.7304 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 378.6438 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-26-000020 · wk-form4_1775519234.xml · derivative · entry 8 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,126.5641 Underlying: Common Shares · 378.6438 shares Expires 2028-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 65.9467 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-26-000020 · wk-form4_1775519234.xml · derivative · entry 7 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,685.3278 Underlying: Common Shares · 65.9467 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Granat JillSee Remarks
|
GrantPerformance Share Units · Derivative | 307.5991 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-26-000020 · wk-form4_1775519234.xml · derivative · entry 6 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,847.1206 Underlying: Common Shares · 307.5991 shares Expires 2027-03-15 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 67.8081 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-26-000020 · wk-form4_1775519234.xml · derivative · entry 5 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,902.2554 Underlying: Common Shares · 67.8081 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. F6 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Granat JillSee Remarks
|
GrantRestricted Share Units · Derivative | 34.3219 | $0.00 | $0.00 |
DisclosureSEC source: 0001552022-26-000020 · wk-form4_1775519234.xml · derivative · entry 4 Granat Jill · CIK 0001552022 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,999.8189 Underlying: Common Shares · 34.3219 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 163.5127 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-26-000016 · wk-form4_1775519259.xml · derivative · entry 9 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,055.5127 Underlying: Common Shares · 163.5127 shares Expires 2029-03-15 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted shares units ("2026 PBRSUs") granted to the Reporting Person. The 2026 PBRSUs will have a performance period beginning February 25, 2026 and ending February 25, 2029 and to the extent earned will vest on March 15, 2029. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 44.0459 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-26-000016 · wk-form4_1775519259.xml · derivative · entry 8 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,133.0459 Underlying: Common Shares · 44.0459 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. F10 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 151.4521 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-26-000016 · wk-form4_1775519259.xml · derivative · entry 7 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,649.998 Underlying: Common Shares · 151.4521 shares Expires 2028-03-15 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs will have a performance period beginning February 28, 2025 and ending on February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 29.7106 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-26-000016 · wk-form4_1775519259.xml · derivative · entry 6 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,462.4248 Underlying: Common Shares · 29.7106 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. F8 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Friesner JacquelineSee Remarks
|
GrantPerformance Share Units · Derivative | 151.8101 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-26-000016 · wk-form4_1775519259.xml · derivative · entry 5 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,691.7133 Underlying: Common Shares · 151.8101 shares Expires 2027-03-15 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 30.6254 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-26-000016 · wk-form4_1775519259.xml · derivative · entry 4 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,569.0394 Underlying: Common Shares · 30.6254 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. F5 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Friesner JacquelineSee Remarks
|
GrantRestricted Share Units · Derivative | 16.6873 | $0.00 | $0.00 |
DisclosureSEC source: 0001552051-26-000016 · wk-form4_1775519259.xml · derivative · entry 3 Friesner Jacqueline · CIK 0001552051 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,944.7126 Underlying: Common Shares · 16.6873 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. F4 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vesting will occur on December 15, 2026. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,446.4967 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-26-000012 · wk-form4_1775519253.xml · derivative · entry 10 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,572.4967 Underlying: Common Shares · 1,446.4967 shares Expires 2029-03-15 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted shares units ("2026 PBRSUs") granted to the Reporting Person. The 2026 PBRSUs will have a performance period beginning February 25, 2026 and ending February 25, 2029 and to the extent earned will vest on March 15, 2029. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 264.5093 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-26-000012 · wk-form4_1775519253.xml · derivative · entry 9 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,825.5093 Underlying: Common Shares · 264.5093 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. F11 · derivative.expiration_date: These restricted share units vest in equal annual installments. The vestings will occur on December 15, 2026, December 15, 2027, December 15, 2028 and December 15, 2029. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,376.8922 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-26-000012 · wk-form4_1775519253.xml · derivative · entry 8 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,460.8988 Underlying: Common Shares · 1,376.8922 shares Expires 2028-03-15 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2025 PBRSUs") granted to the Reporting Person. The 2025 PBRSUs have a performance period beginning February 28, 2025 and ending February 28, 2028 and to the extent earned will vest on March 15, 2028. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 131.4536 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-26-000012 · wk-form4_1775519253.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,319.3991 Underlying: Common Shares · 131.4536 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. F9 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026, December 15, 2027 and December 15, 2028. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,107.3659 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-26-000012 · wk-form4_1775519253.xml · derivative · entry 6 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,050.7152 Underlying: Common Shares · 1,107.3659 shares Expires 2027-03-15 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2024 PBRSUs") granted to the Reporting Person. The 2024 PBRSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance based restricted share units to which they relate. Read SEC document |
| April 02, 2026 Filed Apr 6, 2026 23:47 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 142.1828 | $0.00 | $0.00 |
DisclosureSEC source: 0001574771-26-000012 · wk-form4_1775519253.xml · derivative · entry 5 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,569.7681 Underlying: Common Shares · 142.1828 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. F7 · derivative.expiration_date: These restricted share units vest in equal annual installments. The remaining vestings will occur on December 15, 2026 and December 15, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.